The diagnostic value and cost-effectiveness of creatine kinase-MB, myoglobin and cardiac troponin-T for patients with chest pain emergency department observation ward

Hong Kong Journal of Emergency Medicine

Volumn 11, Issue 2, 2004, Pages 85-90

  Choi, Yu Fai ^a   Wong, Tai Wai ^b   Lau, Chor Chiu ^b  

^a PAMELA YOUDE NETHERSOLE EASTERN HOSPITAL   (Hong Kong)

^b NONE

Author keywords

Chest pain; Cost benefit analysis; Creatine kinase; Myoglobin; Troponin

Indexed keywords

CREATINE KINASE MB; MYOGLOBIN; TROPONIN T;

ACUTE HEART INFARCTION; ADULT; ANGINA PECTORIS; ARTICLE; CAUSE OF DEATH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DOCUMENTATION; EMERGENCY WARD; FOLLOW UP; HEART DISEASE; HOSPITAL ADMISSION; HUMAN; INCIDENCE; ISOMER; MAJOR CLINICAL STUDY; OBSERVATION; PROSPECTIVE STUDY; SURVIVAL;

EID: 2342631366     PISSN: 10249079     EISSN: None     Source Type: Journal    
DOI: 10.1177/102490790401100204     Document Type: Article

References (11)

1. Newby LK, Storrow AB, Gibler WB, et al. Bedside multimarker testing for risk stratification in chest pain units: the chest pain evaluation by creatine kinase-MB, myoglobin, and troponin I (CHECKMATE) study. Circulation 2001;103(14):1832-7.
2. Jernberg T, Lindahl B, James S, Ronquist G, Wallentin L. Comparison between strategies using creatine kinase-MB (mass), myoglobin, and troponin T in the early detection or exclusion of acute myocardial infarction in patients with chest pain and a nondiagnostic electrocardiogram. Am J Cardiol 2000;86(12):1367-71, A5.
3. Venge P, Lagerqvist B, Diderholm E, Lindahl B, Wallentin L. Clinical performance of three cardiac troponin assays in patients with unstable coronary artery disease (a FRISC II substudy). Am J Cardiol 2002;89 (9):1035-41.
4. Abbott JA, Scheinman MM. Nondiagnostic electrocardiogram in patients with acute myocardial infarction. Clinical and anatomic correlations. Am J Med 1973;55(5):608-13.
5. Collinson PO, Stubbs PJ, Kessler AC. Multicentre Evaluation of Routine Immunoassay of Troponin T Study. Multicentre evaluation of the diagnostic value of cardiac troponin T, CK-MB mass, and myoglobin for assessing patients with suspected acute coronary syndromes in routine clinical practice. Heart 2003;89 (3):280-6.
6. Heidenreich PA, Alloggiamento T, Melsop K, McDonald KM, Go AS, Hlatky MA. The prognostic value of troponin in patients with non-ST elevation acute coronary syndromes: a meta-analysis. J Am Coll Cardiol 2001;38(2):478-85.
7. Newby LK, Kaplan AL, Granger BB, Sedor F, Califf RM, Ohman EM. Comparison of cardiac troponin T versus creatine kinase-MB for risk stratification in a chest pain evaluation unit. Am J Cardiol 2000;85(7): 801-5.
8. Aviles RJ, Wright RS, Aviles JM, et al. Long-term prognosis of patients with clinical unstable angina pectoris without elevation of creatine kinase but with elevation of cardiac troponin I levels. Am J Cardiol 2002;90(8):875-8.
9. Zimmerman J, Fromm R, Meyer D, et al. Diagnostic marker cooperative study for the diagnosis of myocardial infarction. Circulation 1999;99(13):1671-7.
10. McErlean ES, Deluca SA, van Lente F, et al. Comparison of troponin T versus creatine kinase-MB in suspected acute coronary syndromes. Am J Cardiol 2000;85(4):421-6.
11. McCord J, Nowak RM, McCullough PA, et al. Ninety-minute exclusion of acute myocardial infarction by use of quantitative point-of-care testing of myoglobin and troponin I. Circulation 2001;104(13):1483-8.